Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan D Bos

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 30, 2011
Formation of fibrosis after nonablative and ablative fractional laser therapyBas S Wind, Arne A Meesters, Marije W Kroon, et al.
Photochemistry and Photobiology|October 31, 2002
UVB irradiation of normal human skin favors the development of type-2 T-cells in vivo and in primary dermal cell culturesSergio Di Nuzzo, Regien M R Sylva-Steenland, Cornelis W Koomen, et al.
Hormone Research in Paediatrics|April 4, 2013
High prevalence of autoimmune thyroiditis in children and adolescents with vitiligoMarije W Kroon, Charlotte Vrijman, Charlotte Chandeck, et al.
The Journal of Investigative Dermatology|February 27, 2009
Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patientsJasper G van den Boorn, Debby Konijnenberg, Trees A M Dellemijn, et al.
Journal of the American Academy of Dermatology|June 7, 2011
Ablative fractional laser therapy as treatment for Becker nevus: a randomized controlled pilot studyArne A Meesters, Bas S Wind, Marije W Kroon, et al.
Archives of Dermatological Research|February 18, 2004
Alefacept therapy reduces the effector T-cell population in lesional psoriatic epidermisAmber Y Goedkoop, Menno A de Rie, Daisy I Picavet, et al.
Archives of Dermatology|February 17, 2010
Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasisLidian L A Lecluse, Rieke J B Driessen, Phyllis I Spuls, et al.
The Journal of Allergy and Clinical Immunology|March 7, 2006
Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005Alain Taïeb, Jon Hanifin, Kevin Cooper, et al.
The New England Journal of Medicine|August 15, 2003
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasisVera M R Heydendael, Phyllis I Spuls, Brent C Opmeer, et al.
Archives of Dermatological Research|July 25, 2007
Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitorMarjan de Groot, Marcel B M Teunissen, Jean P Ortonne, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 30, 2011
Formation of fibrosis after nonablative and ablative fractional laser therapyBas S Wind, Arne A Meesters, Marije W Kroon, et al.
Photochemistry and Photobiology|October 31, 2002
UVB irradiation of normal human skin favors the development of type-2 T-cells in vivo and in primary dermal cell culturesSergio Di Nuzzo, Regien M R Sylva-Steenland, Cornelis W Koomen, et al.
Hormone Research in Paediatrics|April 4, 2013
High prevalence of autoimmune thyroiditis in children and adolescents with vitiligoMarije W Kroon, Charlotte Vrijman, Charlotte Chandeck, et al.
The Journal of Investigative Dermatology|February 27, 2009
Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patientsJasper G van den Boorn, Debby Konijnenberg, Trees A M Dellemijn, et al.
Journal of the American Academy of Dermatology|June 7, 2011
Ablative fractional laser therapy as treatment for Becker nevus: a randomized controlled pilot studyArne A Meesters, Bas S Wind, Marije W Kroon, et al.
Archives of Dermatological Research|February 18, 2004
Alefacept therapy reduces the effector T-cell population in lesional psoriatic epidermisAmber Y Goedkoop, Menno A de Rie, Daisy I Picavet, et al.
Archives of Dermatology|February 17, 2010
Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasisLidian L A Lecluse, Rieke J B Driessen, Phyllis I Spuls, et al.
The Journal of Allergy and Clinical Immunology|March 7, 2006
Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005Alain Taïeb, Jon Hanifin, Kevin Cooper, et al.
The New England Journal of Medicine|August 15, 2003
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasisVera M R Heydendael, Phyllis I Spuls, Brent C Opmeer, et al.
Archives of Dermatological Research|July 25, 2007
Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitorMarjan de Groot, Marcel B M Teunissen, Jean P Ortonne, et al.
Pageof 9